DeepMind spin-off aims to halve drug discovery times following Big Pharma deals
Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.The head of Google DeepMind believes its drug discovery spinout will halve the time taken to find new medicines,…